Advertisement

Topics

Trellis Bioscience Company Profile

17:15 EDT 23rd March 2019 | BioPortfolio

Monoclonal antibody technology was the research breakthrough of the 1980’s. With the discovery by Milstein and Kohler in Cambridge, England, Hybritech became the first company dedicated to the production of monoclonal antibodies, commercializing the first diagnostic tests and leading to two subsequent companies that furthered monoclonal antibody development, GenProbe and IDEC. The use of monoclonal antibodies as therapeutics was limited because the human body developed an immune response to the early generation drugs; this problem was not circumvented until methods to generate or engineer human monoclonal antibodies were developed in the 1990’s. Protein based (antibody) therapeutics are now rapidly finding their way into the forefront of modern day medicine. The promise of this novel class of drugs is recognized widely within the pharmaceutical and biotechnology industries. Over 250 companies and research entities have monoclonal antibody therapeutics, either in clinical or pre-clinical development. Market penetration of monoclonal antibodies worldwide is estimated to reach $40 billion by 2018.

Location

2-B Corporate Drive
South San Francisco
California
94080
United States of America

Contact

Phone: 650.616.1100
Fax: 650.589.4860
Email: info@trellisbio.com


News Articles [369 Associated News Articles listed on BioPortfolio]

Aytu BioScience, Inc.: Aytu BioScience Announces Pricing of $13.2 Million Underwritten Public Offering

ENGLEWOOD, CO / ACCESSWIRE / October 5, 2018 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products addressing significant ...

Aytu BioScience, Inc.: Aytu BioScience Announces Closing of $15.2 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option

ENGLEWOOD, CO / ACCESSWIRE / October 10, 2018 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products addressing significant...

Twist Bioscience Files for $86.3M IPO

Today, Twist Bioscience filed an S-1 with the U.S. Securities and Exchange Commission (SEC), announcing its intent to undergo an initial public offering. The filing shows that Twist intends to raise $...

Aytu BioScience, Inc.: Aytu BioScience Reports 55% Sequential Revenue Growth in Q1 FY19; Adds Tuzistra(R) XR to Portfolio

Company Posts Highest Ever Quarterly Revenue ENGLEWOOD, CO / ACCESSWIRE / November 7, 2018 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on global commercializa...

Aytu BioScience, Inc.: Aytu BioScience to Present at 11th Annual LD Micro Main Event Investor Conference on December 5, 2018

ENGLEWOOD, CO / ACCESSWIRE / November 27, 2018 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products addressing significan...

Cyclenium Pharma and Haplogen Bioscience Announce Granting of EUREKA Label and Funding to ...

Cyclenium Pharma Inc.Helmut Thomas, Ph.D., DABT, +1-819-571-4296President, CEO & CSOhthomas@cyclenium.comorHaplogen Bioscience GmbHGeorg Casari, Ph.D., +43-1-9165522Chief Exec...

Aytu BioScience, Inc.: Aytu BioScience Announces Publication of Manuscript Summarizing Results from the Ongoing Natesto(R) Spermatogenesis Study

Sperm Concentration, Motility, and Total Motile Sperm Count Remain Within Normal Ranges in Hypogonadal Men Taking Natesto ENGLEWOOD, CO / ACCESSWIRE / September 17, 2018 / Aytu BioScience, Inc. (NA...

Aytu BioScience, Inc.: Aytu BioScience Enters $3 Billion Cough and Cold Market and Expands Primary Care Portfolio, with Exclusive U.S. Licensing of Revenue-Generating, FDA-Approved Antitussive Tuzistra(R) XR

Armistice Capital to Make $5M Strategic Investment in Conjunction with Tuzistra XR Acquisition to Accelerate Growth ENGLEWOOD, CO / ACCESSWIRE / November 5, 2018 / Aytu BioScience, Inc. (NASDAQ: AY...

Drugs and Medications [2 Associated Drugs and Medications listed on BioPortfolio]

Idkit hp one [exalenz bioscience ltd.]

Package Insert IDkit:Hp™ for the Exalenz BreathID® System BREATH TEST FOR DETECTION of H. pylori

Natesto [aytu bioscience, inc.]

These highlights do not include all the information needed to use NATESTO safely and effectively. See full prescribing information for NATESTO.Natesto (testosterone) nasal gel CIII Initial U.S. Approv...

PubMed Articles [74 Associated PubMed Articles listed on BioPortfolio]

Experimental study of performance enhanced IM/DD transmissions combining 4D Trellis coded modulation with precoding.

We propose to combine 4D trellis-coded modulation (TCM) with transmitter-side Tomlinson-Harashima precoding (THP) in IM/DD transmissions, and experimentally investigate the achieved performance improv...

Correction.

Editorial: Bioscience of D-amino Acid Oxidase From Biochemistry to Pathophysiology.

Correction: Proteasome subunit-α type-6 protein is post-transcriptionally repressed by the microRNA-4490 in diabetic nephropathy.

Improving Undergraduate Life Science Education for the Biosciences Workforce: Overcoming the Disconnect between Educators and Industry.

The BioHealth Capital Region (Maryland, Virginia, and Washington, DC; BHCR) is flush with colleges and universities training students in science, technology, engineering, and mathematics disciplines a...

Clinical Trials [5 Associated Clinical Trials listed on BioPortfolio]

Microplasmin Administered Via the Trellis-8 Infusion System for Treatment of Acute Iliofemoral DVT

A single centre, single-arm study to evaluate safety and efficacy of microplasmin administration via the Trellis-8 Infusion System in patients with acute iliofemoral DVT

Evaluation of 3-V Bioscience-2640 to Reduce de Novo Lipogenesis in Subjects With Characteristics of Metabolic Syndrome

Metabolic syndrome increases the risk for development of heart disease. Another condition associated with metabolic syndrome is fatty liver disease which is also referred to as nonalcoholi...

Trial of HPV Vaccine in Healthy Adult and Adolescent Female

This is a randomized, double-blind, active-controlled, phaseI/II clinical trial to enroll 200 healthy female including 80 healthy adult aged 19 to 26 years and 120 adolescents aged 9 to 13...

Pain Relief During Photodynamic Therapy for Actinic Keratoses With a New Irradiation Protocol

This pilot study will try to minimize the pain during exposure to a new red light source (RhodoLED®, Biofrontera Bioscience GmbH, Leverkusen, Germany) used for PDT without compromising it...

Skin Safety Profile of Different Exposure to the Light Emitting Diode (LED) in Healthy Subjects

Photomodulation is a process which manipulates or regulates cell activity using light sources without thermal effect. Different studies have investigated the use of non-thermal low dose li...

Companies [317 Associated Companies listed on BioPortfolio]

Trellis Bioscience, Inc.

Trellis Bioscience, Inc. is a private, venture-funded, antibody company focused on the discovery and development of unique therapeutic antibodies from human B cells. To exploit th...

Trellis Health Partners

For over 21 years, Trellis Health Partners has been providing a unique combination of technology and outsourcing solutions to the healthcare industry. Serving clients nationwide f...

Trellis Rx

Trellis Rx helps health systems change the way patients experience specialty medication therapy. We reduce risk for health systems by partnering with them to fund, build and opera...

The Idaho Bioscience Association

The Idaho Bioscience Association is a non-profit organization that brings together corporate, academic and political leaders to educate the public and to promote bioscience activities in the state. B...

Sprint Bioscience

Sprint Bioscience AB (publ) is part of the new Swedish pharmaceutical industry. The company has the goal to develop drug candidates for the global pharmaceutical market within the...

More Information about "Trellis Bioscience" on BioPortfolio

We have published hundreds of Trellis Bioscience news stories on BioPortfolio along with dozens of Trellis Bioscience Clinical Trials and PubMed Articles about Trellis Bioscience for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Trellis Bioscience Companies in our database. You can also find out about relevant Trellis Bioscience Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...


Corporate Database Quicklinks



Searches Linking to this Company Record